Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy. 1978

H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura

The effect of radiotherapy on peripheral blood lymphocytes (PBL) of lung cancer and the effect of BCG cell-wall skeleton (BCG-CWS) on recovery of impaired PBL were examined. A remarkable depression of the absolute number of E- or EAC-rosette cells and of the response of PBL to mitogens were observed immediately after radiotherapy, and these continued for several months. With BCG-CWS immunotherapy, the response of PBL to phytohemagglutinin recovered rapidly, compared with non-vaccinated patients. The response of PBL to pokeweed mitogen seemed to give similar results. These results suggested that BCG-CWS injection to the patient receiving radiotherapy was effective for recovery of T-cell response.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D005260 Female Females

Related Publications

H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
December 1976, Gan,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
April 1979, Cancer,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
October 1977, Kekkaku : [Tuberculosis],
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
November 1977, Nihon Kyobu Shikkan Gakkai zasshi,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
May 1978, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
April 1983, Nihon Geka Gakkai zasshi,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
August 2001, International immunopharmacology,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
August 1975, Gan,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nishikawa, and S Yasaki, and T Yoshimoto, and M Sakatani, and M Itoh, and T Masuno, and M Namba, and T Ogura, and F Hirao, and I Azuma, and Y Yamamura
January 2013, European journal of gynaecological oncology,
Copied contents to your clipboard!